Bexmarilimab for AML Granted Orphan Drug Designation
https://pixabay.com/en/hands-teamwork-team-spirit-cheer-up-1939895/

Bexmarilimab for AML Granted Orphan Drug Designation

Currently available therapeutics may not be adequately effective in the fight to treat late-stage acute myeloid leukemia (AML) or myelodysplastic syndromes (MDS). Researchers and drug developers are working to identify…

Continue Reading Bexmarilimab for AML Granted Orphan Drug Designation